Kayauchi et al. analyzed 226 patients with lung cancer undergoing cytotoxic chemotherapy, and reported that patients with decreased albumin levels during treatment significantly suffered from febrile neutropenia toxicity [141]. This evidence concerns the gene ALB and lung cancer.